Skip to main content
Article
Outcomes following transcatheter transseptal versus transapical mitral valve-in-valve and valve-in-ring procedures
J Cardiovasc Thorac Res (2018)
  • Anthony A. Donato, Tower Health
  • Salik Nazir, Reading Hospital – Tower Health
  • Saroj Lohani, Reading Hospital – Tower Health
  • Niranjan Tachamo, Reading Hospital – Tower Health
  • Muhammad S Khan, Reading Hospital – Tower Health
  • Bidhya Timilsina, Reading Hospital – Tower Health
  • Faraz K Luni, Reading Hospital – Tower Health
Abstract
Introduction: Transcatheter mitral valve-in-valve (ViV) & valve-in-ring (ViR) are relatively novel therapeutic alternatives for patients with degenerated bioprostheses or failed annuloplasty rings whose reoperative risk is too high. The predominant procedural access for both procedures is transapical or transseptal. However, whether there are differences in outcomes of this procedure using transseptal versus transapical access has not yet been defined. Methods: We conducted a systematic review of all published articles from MEDLINE and EMBASE to explore the outcomes of these two procedural approaches. Results:total of 55 studies including 183 patients (154 ViV and 29 ViR) were included. Patients that underwent ViV (101 transapical and 53 transseptal) using the transseptal approach required more iatrogenic atrial septal defect (ASD) closure (19% versus 0.0 %; P < 0.001) and hence had a lower device success rate (68% versus 89%; P = 0.001). However, there was no significant difference between the two groups in procedural success and all-cause mortality at 30 days. Overall severe bleeding complications (major or life threatening) were not different the two groups (3.7% versus 7.9%; P = 0.321). In the ViR group (19 transapical and 10 transseptal), no difference in procedural success, device success or 30-day outcomes were identified between transseptal and transapical groups, although sample size was small. Conclusion: In conclusion, mitral ViV and ViR using the two different procedural approaches appear to confer equal and reasonable 30-day outcomes.
Publication Date
December 9, 2018
DOI
10.15171/jcvtr.2018.31
Citation Information
Anthony A. Donato, Salik Nazir, Saroj Lohani, Niranjan Tachamo, et al.. "Outcomes following transcatheter transseptal versus transapical mitral valve-in-valve and valve-in-ring procedures" J Cardiovasc Thorac Res Vol. 10 Iss. 4 (2018) p. 182 - 186
Available at: http://works.bepress.com/anthony-donato/27/